Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
NCT00105976
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
MM-093
Sponsor
Merrimack Pharmaceuticals